Pfizer receives US$ 2.15 billion in patent damages

被引：0

|

作者：

Sklan, Alexandra

机构：

来源：

PHARMACEUTICAL PATENT ANALYST | 2013年 / 2卷 / 05期

关键词：

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

收藏

页码：583 / 583

页数：1

相关论文

共 50 条

[1] Menarini receives US patent for enantyum
不详
[J]. DRUG NEWS & PERSPECTIVES, 1996, 9 (09) : 550 - 550
[2] Dual Domain technology receives US patent
不详
[J]. MATERIALS WORLD, 2001, 9 (01) : 6 - 6
[3] Level-radar gauge receives US patent
不详
[J]. HYDROCARBON PROCESSING, 1996, 75 (01): : 40 - 41
[4] US court invalidates Pfizer's Celebrex (R) patent
不详
[J]. PHARMACEUTICAL PATENT ANALYST, 2014, 3 (03) : 224 - 224
[5] Memsift receives US patent for its core MD technology
[J]. Membrane Technology, 2022, 2022 (02)
[6] Somatix receives US patent covering method for treating glioma
不详
[J]. DRUG NEWS & PERSPECTIVES, 1996, 9 (06) : 367 - 367
[7] Florida court awards US$ 145 billion in damages against US tobacco companies
Charatan, F
[J]. BULLETIN OF THE WORLD HEALTH ORGANIZATION, 2000, 78 (08) : 1062 - 1062
[8] The $5 Billion Hop: Glatiramer Acetate and the US Patent System
Patel, Neeraj G.
Kesselheim, Aaron S.
[J]. JOURNAL OF LAW MEDICINE & ETHICS, 2022, 50 (04): : 852 - 856
[9] Pfizer buys Trillium and its CD47 candidates for US$2.3 billion
Mullard, Asher
[J]. NATURE REVIEWS DRUG DISCOVERY, 2021, 20 (10) : 728 - 728
[10] Pfizer buys Trillium and its CD47 candidates for US$2.3 billion
Asher Mullard
[J]. Nature Reviews Drug Discovery, 2021, 20 : 728 - 728

← 1 2 3 4 5 →